BridgeBio Pharma (BBIO) Research & Development (2018 - 2026)
BridgeBio Pharma's Research & Development came in at $149.45 million for Q2 2026, up 34.4% from $111.23 million a year earlier and up 18.0% from the prior quarter.
Powered by 
Analysis
BridgeBio Pharma (BBIO) Research & Development (2018 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, BridgeBio Pharma reported Research & Development of $505.38 million, up 6.7% year-over-year; for FY2025, it came in at $451.95 million, down 10.8% from FY2024.
- Research & Development carries a five-year compound annual growth rate of 6.0% (FY2020 to FY2025).
- Going back by year, Research & Development was $506.46 million in FY2024 (+11.1%), $455.71 million in FY2023 (+14.1%), $399.46 million in FY2022 (-11.4%) and $451.02 million in FY2021 (+33.8%).
- The Q2 2026 figure represents the highest quarterly Research & Development in data going back to Q2 2018.
- Year-over-year, Research & Development increased in three of the last eight quarters, with growth averaging 0.4%.
- The fastest year-over-year change in Research & Development over five years came in Q1 2024 (growth of 51.8%), and the weakest in Q4 2022 (a decline of 25.6%).
- Business Quant data shows BBIO's Research & Development at $126.64 million (Q1 2026), $116.42 million (Q4 2025) and $112.87 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 3.65 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 2.34 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 9.74 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | -2.85 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | -4.05 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 1.87 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 1.76 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 2.81 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 993.80 Mn |
| 10 | BridgeBio Pharma | 13.01 Bn | 10.12 Bn | 228.63 Mn | 149.45 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 149.45 Mn |
| Mar 31, 2026 | 126.64 Mn |
| Dec 31, 2025 | 116.42 Mn |
| Sep 30, 2025 | 112.87 Mn |
| Jun 30, 2025 | 111.23 Mn |
| Mar 31, 2025 | 111.43 Mn |
| Dec 31, 2024 | 130.35 Mn |
| Sep 30, 2024 | 120.44 Mn |
| Jun 30, 2024 | 114.70 Mn |
| Mar 31, 2024 | 140.97 Mn |
| Dec 31, 2023 | 130.23 Mn |
| Sep 30, 2023 | 125.14 Mn |
| Jun 30, 2023 | 107.49 Mn |
| Mar 31, 2023 | 92.86 Mn |
| Dec 31, 2022 | 90.90 Mn |
| Sep 30, 2022 | 92.51 Mn |
| Jun 30, 2022 | 108.40 Mn |
| Mar 31, 2022 | 107.65 Mn |
| Dec 31, 2021 | 122.20 Mn |
| Sep 30, 2021 | 104.31 Mn |
API Access
BridgeBio Pharma Research & Development API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=research-and-development&ticker=BBIO&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "research-and-development", "ticker": "BBIO", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=research-and-development&ticker=BBIO&period=max&api_key=YOUR_API_KEY");
const data = await res.json();